SenzaGen

SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD test platform, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings....

Safetytesting of chemical compounds,skin sensitization,respiratory sensitization,sensitization testing ,and animal free testing

Senzagen operates in the Biotechnology industry.

Senzagen's revenue is 1m - 10m

Senzagen has 11 - 50 employees.